Subtype
Bladder Neoplasm
CI-CAN-00001978Explore in graph →
Non-malignant390 active trials10 approved drugs25 evidence items
Loading cancer entity…
Loading cancer entity…
Subtype
CI-CAN-00001978Explore in graph →
Clinical trials
1,701 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT05739812 | The Efficacy and Safety of Chinese Domestic Surgical Robot System in Urological Telesurgery | unknown | N/A | 100 | The Affiliated Hospital of Qingdao UniversityOTHER | 1 | Jul 14, 2023 | clinicaltrials |
| NCT02948543 | Adding Mitomycin to BCG as Adjuvant Intravesical Therapy for High-risk Non-Muscle-invasive Bladder Cancer(BCG+MM) | unknown | Phase 3 | 501 | University of SydneyOTHER | 2 | Jun 18, 2023 |
| clinicaltrials |
| NCT05885204 | RARC vs LRC in A Multicenter Cohort Study | unknown | — | 3,815 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityOTHER | 0 | Jun 1, 2023 | clinicaltrials |
| NCT05856825 | Long-Term Outcomes of Robot-Assisted Radical Cystectomy: A Real-World Study | unknown | — | 4,500 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityOTHER | 0 | May 12, 2023 | clinicaltrials |
| NCT04391790 | MOdified Urinary Conduit to Lower Strictures After radIcal Cystectomy(MOSAIC) | unknown | N/A | 300 | Jørgen Bjerggaard JensenOTHER | 1 | Apr 27, 2023 | clinicaltrials |
| NCT05833997 | Safety Analysis and Oncological Outcomes in HoLERT vs TURBT | unknown | N/A | 100 | Instituto do Cancer do Estado de São PauloOTHER | 1 | Apr 27, 2023 | clinicaltrials |
| NCT01675219 | Fluorescence Cystoscopy and Optimized MMC in Recurrent Bladder Cancer (FinnBladder 9) | unknown | Phase 3 | 400 | Turku University HospitalOTHER_GOV | 1 | Apr 13, 2023 | clinicaltrials |
| NCT05084586 | Comparison of the Efficacy and Safety of Continuous and Single-Dose Intravesical Epirubicin Instillation | unknown | N/A | 100 | Ankara Training and Research HospitalOTHER | 1 | Mar 28, 2023 | clinicaltrials |
| NCT05787938 | Role of MRI in Assessment of the Urinary Bladder Wall Post Transurethral Tumor Resection | unknown | — | 58 | Assiut UniversityOTHER | 0 | Mar 28, 2023 | clinicaltrials |
| NCT04543110 | Radiation and Durvalumab Immunotherapy As Neoadjuvant Treatment for MIBC(RADIANT) | unknown | Phase 2 | 16 | Ottawa Hospital Research InstituteOTHER | 1 | Mar 23, 2023 | clinicaltrials |
| NCT05767528 | Clinical Study of Neoadjuvant Therapy Outcome Prediction of Muscle-invasive Bladder Cancer Based on PTC Drug Sensitivity Detection | unknown | — | 40 | Chinese PLA General HospitalOTHER | 1 | Mar 14, 2023 | clinicaltrials |
| NCT05429866 | Immunological Variables Associated to ICI Toxicity in Cancer Patients | unknown | Phase 2 | 441 | Jules Bordet InstituteOTHER | 1 | Mar 8, 2023 | clinicaltrials |
| NCT04799847 | Catumaxomab in Patients With Non-Muscle-Invasive Bladder Cancer Who Have Failed or Are Intolerant to BCG Vaccine | unknown | Phase 1 / Phase 2 | 161 | LintonPharm Co.,Ltd.INDUSTRY | 1 | Feb 13, 2023 | clinicaltrials |
| NCT05643807 | Bladder Washing Cytology for Detection of Urothelial Carcinoma Using Catheter or Flexible Cystoscope: Which is Better?(BWash) | unknown | N/A | 414 | Centre Hospitalier Universitaire VaudoisOTHER | 1 | Feb 10, 2023 | clinicaltrials |
| NCT05508568 | A Performance Evaluation Study of Arquer's MCM5 Elisa Test (ADXBLADDER) to Aid in the Monitoring of Recurrence in Non-Muscle Invasive Bladder Cancer | unknown | — | 650 | Arquer Diagnostics LtdINDUSTRY | 1 | Feb 1, 2023 | clinicaltrials |
| NCT05697224 | Aschistosoma Haematobiumspecific microRNAas a Tumor Marker for Early Diagnosis and Prognosis of Bilharzial Bladder Cancer in Eygpt | unknown | N/A | 50 | Sohag UniversityOTHER | 0 | Jan 25, 2023 | clinicaltrials |
| NCT05445648 | Comprehensive Bladder Preservation Therapy on Patients With Muscle Invasive Bladder Cancer(CBPTMI) | unknown | Phase 2 | 65 | First Affiliated Hospital Xi'an Jiaotong UniversityOTHER | 1 | Dec 28, 2022 | clinicaltrials |
| NCT05611762 | Narrow-band Imaging Diagnostic Classification System for Bladder Tumors(NBI) | unknown | — | 1,064 | Qilu Hospital of Shandong University (Qingdao)OTHER | 1 | Dec 19, 2022 | clinicaltrials |
| NCT05480735 | EffectiveNess of a Multimodal preHAbilitation Program in patieNts With Bladder canCEr Undergoing Cystectomy(ENHANCE) | unknown | N/A | 154 | The Netherlands Cancer InstituteOTHER | 1 | Oct 31, 2022 | clinicaltrials |
| NCT03529890 | Radio-Immunotherapy Before Cystectomy in Locally Advanced Urothelial Carcinoma of the Bladder(RACE IT) | unknown | Phase 2 | 33 | Technical University of MunichOTHER | 1 | Oct 20, 2022 | clinicaltrials |
| NCT05564897 | Oncolytic Adenovirus Combined With PD-1 Inhibitor in Patients With Non-muscle-invasive Bladder Cancer | unknown | Phase 2 | 25 | Zhejiang Cancer HospitalOTHER | 1 | Oct 4, 2022 | clinicaltrials |
| NCT05559177 | An Open, Dose-escalation Clinical Study of Chimeric Exosomal Tumor Vaccines for Recurrent or Metastatic Bladder Cancer | unknown | Early Phase 1 | 9 | Shanghai Pudong HospitalOTHER | 1 | Sep 29, 2022 | clinicaltrials |
| NCT05503563 | A Proposed Tetra-modal Treatment Protocol for Muscle Invasive Urothelial Carcinoma of the Urinary Bladder | unknown | — | 50 | Assiut UniversityOTHER | 1 | Aug 16, 2022 | clinicaltrials |
| NCT03844256 | A Study of Mitomycin-c/ Capecitabine ChemoRadiotherapy Combined With Nivolumab Monotherapy or Ipilumimab and Nivolumab, as Bladder Sparing Curative Treatment for Muscle Invasive Bladder Cancer: the CRIMI Study(CRIMI) | unknown | Phase 1 / Phase 2 | 50 | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)OTHER | 1 | Aug 12, 2022 | clinicaltrials |
| NCT03934827 | MRx0518 in Patients With Solid Tumours Waiting Surgical Removal of the Tumour(MICROBIOME) | unknown | Phase 1 | 120 | Imperial College LondonOTHER | 1 | Aug 11, 2022 | clinicaltrials |
| NCT04282876 | Influence of Hormone Treatment in Radiation Therapy for Bladder Cancer | unknown | — | 60 | Aarhus University HospitalOTHER | 1 | Aug 8, 2022 | clinicaltrials |
| NCT05488353 | A Clinical Study of Disitamab Vedotin for Injection Combined With Penpulimab Injection in Neoadjuvant Therapy for Patients With HER2-expressing Cisplatin-intolerant cT2-T4aNxM0 Bladder Urothelial Carcinoma | unknown | Phase 4 | 48 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen UniversityOTHER | 0 | Aug 4, 2022 | clinicaltrials |
| NCT05139134 | Immunohistochemical Expression of CXCL5 as a Valuable Prognostic Marker in Urinary Bladder Urothelial Carcinoma | unknown | — | 50 | Sohag UniversityOTHER | 1 | Jul 29, 2022 | clinicaltrials |
| NCT05467267 | Personalized Urine Biomarker for Patients With Bladder Cancer | unknown | — | 20 | Ziv HospitalOTHER_GOV | 0 | Jul 20, 2022 | clinicaltrials |
| NCT04839029 | Bipolar Versus Mono-polar Needlescopic En Bloc TUR-BT | unknown | N/A | 200 | Benha UniversityOTHER | 1 | Jul 19, 2022 | clinicaltrials |
| NCT05429710 | SOX2 & PDL1 Expression on Urinary Bladder Carcinoma | unknown | — | 60 | Sohag UniversityOTHER | 0 | Jun 23, 2022 | clinicaltrials |
| NCT05392634 | Multicentral Preventive Antibiotics With Cystectomy Within Enhanced Recovery After Surgery(MACS) | unknown | Phase 3 | 98 | N.N. Petrov National Medical Research Center of OncologyOTHER | 1 | May 31, 2022 | clinicaltrials |
| NCT04235556 | Integrated Care Pathway in Oncology (PASSION)(PASSION) | unknown | — | 1,800 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | May 13, 2022 | clinicaltrials |
| NCT04718948 | Multimodal Spectroscopy to Detect Urothelial Cancer in Urine | unknown | — | 500 | University of FlorenceOTHER | 1 | May 9, 2022 | clinicaltrials |
| NCT04770974 | Urothelial Cancer Tumor Bio-markers and Physical-spectroscopic Characteristic | unknown | — | 200 | University of FlorenceOTHER | 1 | May 9, 2022 | clinicaltrials |
| NCT05344937 | Validation Study of Uromonitor in High Risk Microhematuria Patients | unknown | — | 343 | Clinica Universidad de Navarra, Universidad de NavarraOTHER | 1 | May 2, 2022 | clinicaltrials |
| NCT04784507 | En-Bloc Resection of Bladder Tumors | unknown | Phase 2 | 60 | Betul KartalOTHER | 1 | Apr 12, 2022 | clinicaltrials |
| NCT04339933 | Detection of FGFR Gene Mutations in the Tumor Tissue and Urine of Patients With Urothelial Carcinoma | unknown | — | 92 | Ho Kyung SeoOTHER_GOV | 0 | Apr 7, 2022 | clinicaltrials |
| NCT04876313 | An Open Label, Single-arm, Phase 2 Study of Neoadjuvant Nivolumab and Nab-paclitaxel Before Radical Cystectomy for Patients With Muscle-invasive Bladder Cancer (NURE-Combo)(NURE-Combo) | unknown | Phase 2 | 29 | IRCCS San RaffaeleOTHER | 1 | Apr 6, 2022 | clinicaltrials |
| NCT04819399 | Investigation of Safety and Tolerability of Catumaxomab in Patients With NMIBC | unknown | Phase 1 | 30 | Lindis Biotech GmbHINDUSTRY | 1 | Apr 5, 2022 | clinicaltrials |
| NCT03759496 | Efficacy of Durvalumab in Non-muscle-invasive Bladder Cancer | unknown | Phase 2 | 39 | Hellenic GenitoUrinary Cancer GroupOTHER | 1 | Mar 23, 2022 | clinicaltrials |
| NCT03993249 | Nivolumab Plus Chemoradiotherapy in Patients With Muscle-invasive Bladder Cancer (MIBC) Not Undergoing Cystectomy | unknown | Phase 2 | 78 | Hellenic GenitoUrinary Cancer GroupOTHER | 1 | Mar 23, 2022 | clinicaltrials |
| NCT05077852 | Intravesical Prostatic Protrusion Mimicking Urothelial Cell Carcinoma of the Bladder | unknown | — | 194 | Ankara Training and Research HospitalOTHER | 1 | Mar 15, 2022 | clinicaltrials |
| NCT03762161 | A Phase II Study of Lonsurf (TAS-102) in Metastatic Platinum and Checkpoint Inhibitor-resistant Bladder Cancer | unknown | Phase 2 | 22 | Rahul ParikhOTHER | 1 | Mar 10, 2022 | clinicaltrials |
| NCT05262166 | Opioid Free Anesthesia in Prolonged Surgery | unknown | N/A | 34 | Mansoura UniversityOTHER | 1 | Mar 2, 2022 | clinicaltrials |
| NCT05235607 | Personalized Immune Cell Therapy Targeting Neoantigen of Malignant Solid Tumors | unknown | Phase 1 | 60 | Sichuan UniversityOTHER | 1 | Feb 11, 2022 | clinicaltrials |
| NCT04638569 | Comparison of Obturator Nerve Block With Ultrasound Guidance and Anatomical Signs | unknown | N/A | 116 | Muğla Sıtkı Koçman UniversityOTHER | 1 | Feb 7, 2022 | clinicaltrials |
| NCT05220124 | A Study of Probiotics Administration in the Immunotherapy of Urothelial Bladder Carcinoma | unknown | Phase 4 | 190 | Tianjin Medical University Second HospitalOTHER | 1 | Feb 2, 2022 | clinicaltrials |
| NCT05180851 | Safety and Efficacy of Recombinant Oncolytic Adenovirus L-IFN Injection in Relapsed/Refractory Solid Tumors Clinical Study(YSCH-01) | unknown | Early Phase 1 | 28 | Shanghai Fengxian District Central HospitalOTHER | 1 | Feb 1, 2022 | clinicaltrials |
| NCT02992990 | Bladder Tumor Biopsy Study to Improve Preoperative Determination of Stage and Grade | unknown | N/A | 30 | Baylor College of MedicineOTHER | 1 | Jan 19, 2022 | clinicaltrials |
Data updated 22 days agoSource updated Jul 14, 2023source: clinicaltrials